468 results on '"Tufano, Antonella"'
Search Results
2. Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis
3. Rate and predictors of thromboprophylaxis in internal medicine wards: Results from the AURELIO study
4. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study
5. How to manage anticoagulation for cancer-associated thrombosis and atrial fibrillation in cancer
6. Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies
7. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study
8. Atrial cardiomyopathy: Pathophysiology and clinical implications
9. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review.
10. Challenging report of cardiopulmonary bypass in 16th week pregnant patient with endoventricular mass
11. Speckle tracking echocardiography in patients with systemic lupus erythematosus: A meta-analysis
12. A novel mutation in the fibrinogen γ-chain gene c.952G>T, p. (Gly318Cys) leading to hypo dysfibrinogenemia
13. Can echocardiography improve the prediction of thromboembolic risk in atrial fibrillation? Evidences and perspectives
14. Cerebral venous sinus thrombosis as a complication of lumbar puncture
15. Prevention of relapse in patients with acquired thrombotic thrombocytopenic purpura undergoing elective surgery: a case series
16. Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study
17. Left ventricular diastolic abnormalities other than valvular heart disease in antiphospholipid syndrome: An echocardiographic study
18. The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies
19. Venous thromboembolism and major bleeding in severe and critical COVID-19 hospitalized patients.
20. Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years.
21. Tel-Aviv, ville blanche : la construction d’un objet patrimonial et ses effets sur le développement de la ville
22. Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism
23. Eculizumab in pregnancy: a narrative overview
24. Position paper of the Italian Society of Internal Medicine (SIMI) on prophylaxis and treatment of venous thromboembolism in patients with cancer
25. A novel mutation in the fibrinogen γ-chain gene c.952G>T, p. (Gly318Cys) leading to hypo dysfibrinogenemia
26. Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years
27. Chapitre 11. Écosystèmes d’innovation ouverte « nouvelle génération » : Living Labs, communs d’innovation et organisation apprenante
28. Hypocalcemia and hypophosphatemia after treatment with zoledronic acid in a patient with AL amyloidosis
29. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference
30. Clinical Data of Neonatal Systemic Thrombosis
31. Safety of the pulmonary embolism rule‐out criteria rule: Findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) registry.
32. Cyclic supplementation of 5-MTHF is effective for the correction of hyperhomocysteinemia
33. The new Italian registry of infantile thrombosis (RITI): A reflection on its journey, challenges and pitfalls
34. Prophylaxis of venous thromboembolism in Internal Medicine Units: the RAMs issue
35. Italian intersociety consensus on DOAC use in internal medicine
36. A Rare Case of Tricuspid Valve Libman–Sacks Endocarditis in a Pregnant Woman with Primary Antiphospholipid Syndrome
37. Comparison of Full-Dose vs Moderate-Dose Systemic Thrombolysis for the Treatment of Patients With Acute Pulmonary Embolism
38. Ensuring medication adherence with direct oral anticoagulant drugs: Lessons from adherence with vitamin K antagonists (VKAs)
39. Inferior Vena Cava Agenesis and Deep Vein Thrombosis in the Young: A Review of the Literature and Local Experience
40. Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre.
41. The “very rare” unusual sites venous thromboses
42. Correction: Di Micco et al. Clinical Differences between COVID-19 and a COVID-like Syndrome. J. Clin. Med. 2021, 10, 2519
43. Promoting Social Interaction through Participatory Architecture. Experimentation, Experience, Evaluation in a Social Housing Complex (Grand’Goule, Poitiers, 1974–2021)
44. Optimizing antithrombotic therapy for atrial fibrillation in cancer
45. Systemic Catheter-Related Venous Thromboembolism in Children: Data From the Italian Registry of Pediatric Thrombosis.
46. Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study
47. Filling the gap between science & clinical practice: Prevention of stroke recurrence
48. Role of New Potential Biomarkers in the Risk of Thromboembolism in Atrial Fibrillation
49. « 3. Les grands combats », dans Collectif DAM, Matérialité
50. « 2. Du factuel au définitionnel », dans Collectif DAM, Matérialité
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.